Shandong Buchang Pharma
在20年的发展中，步长制药构建了清晰的发展战略，“聚焦大病种、培育大品种”，公司以专利中成药为核心，致力于中药现代化，充分发挥了中药在心脑血管这一“大病、慢病”领域中的重要作用，形成了立足心脑血管市场、覆盖中成药传统优势领域、聚焦大病种、培育大品种的立体产品格局。 山东步长制药股份有限公司 (简称"步长制药") 成立于2001年，并于2012年完成股份制改制。2016年7月通过证监会发审会IPO审核，于2016年11月18日成功上市。
Basic Information
- Category: business
- Website: http://www.buchang.com/
Documented Facts
- Phone: 400-678-9828 (No linked source recorded for this statement.)
- Email: kefuzhongxin@buchang.com (No linked source recorded for this statement.)
Evidence and Sources
- Shandong Buchang Pharma — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Shandong Buchang Pharma.
- Canonical profile: https://brandsource.ai/brands/shandong-buchang-pharma
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/shandong-buchang-pharma/json-ld
- Citation profile API: https://brandsource.ai/api/brands/shandong-buchang-pharma/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Structured profile (62/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Shandong Buchang Pharma is listed in business on BrandSource.AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
Known data gaps
- Needs a specific, non-thin summary
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.